Literature DB >> 9331948

Interactions of HLA-B*4801 with peptide and CD8.

E Martinez-Naves1, L D Barber, J A Madrigal, C M Vullo, C Clayberger, S C Lyu, R C Williams, C Gorodezky, T Markow, M L Petzl-Erler, P Parham.   

Abstract

Functional properties of the B*4801 allotype were investigated using HLA class I-deficient 221 cells transfected with B*4801 cDNA. From pool sequence analysis of endogenously bound peptides, B*4801 was shown to select for nonamer peptides having glutamine or lysine at position 2 and leucine at the carboxyl-terminus. In an in vitro cell-cell binding assay, B*4801 binds CD8 alpha homodimers weakly due to the presence of a threonine residue at position 245 in the alpha 3 domain. A mutant B*4801 molecule in which alanine replaces threonine 245, binds CD8 alpha homodimers at levels comparable to those of other HLA class I allotypes. Despite the low affinity of B*4801 for CD8 alpha, alloreactive T-cells that recognize B*4801 molecules expressed by the 221 transfectant are inhibited by anti-CD8 monoclonal antibodies. Analysis of 25 B*48-expressing individuals from various populations showed threonine 245 was encoded by every B*48 allele.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9331948     DOI: 10.1111/j.1399-0039.1997.tb02869.x

Source DB:  PubMed          Journal:  Tissue Antigens        ISSN: 0001-2815


  3 in total

1.  Fine-mapping classical HLA variation associated with durable host control of HIV-1 infection in African Americans.

Authors:  Paul J McLaren; Stephan Ripke; Kimberly Pelak; Amy C Weintrob; Nikolaos A Patsopoulos; Xiaoming Jia; Rachel L Erlich; Niall J Lennon; Carl M Kadie; David Heckerman; Namrata Gupta; David W Haas; Steven G Deeks; Florencia Pereyra; Bruce D Walker; Paul I W de Bakker
Journal:  Hum Mol Genet       Date:  2012-06-19       Impact factor: 6.150

Review 2.  Immunogenetics of HIV disease.

Authors:  Maureen P Martin; Mary Carrington
Journal:  Immunol Rev       Date:  2013-07       Impact factor: 12.988

3.  LILRB2 interaction with HLA class I correlates with control of HIV-1 infection.

Authors:  Arman A Bashirova; Enrique Martin-Gayo; Des C Jones; Ying Qi; Richard Apps; Xiaojiang Gao; Patrick S Burke; Craig J Taylor; Jerome Rogich; Steven Wolinsky; Jay H Bream; Priya Duggal; Shehnaz Hussain; Jeremy Martinson; Amy Weintrob; Gregory D Kirk; Jacques Fellay; Susan P Buchbinder; James J Goedert; Steven G Deeks; Florencia Pereyra; John Trowsdale; Mathias Lichterfeld; Amalio Telenti; Bruce D Walker; Rachel L Allen; Mary Carrington; Xu G Yu
Journal:  PLoS Genet       Date:  2014-03-06       Impact factor: 5.917

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.